January 21, 2021
Obalon Therapeutics, Inc. Investigation
We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ: OBLN)
Join Case →